Applied DNA Sciences, Inc.
APDN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $304 | $983 | $1,197 | $813 |
| % Growth | -69% | -17.8% | 47.2% | – |
| Cost of Goods Sold | $299 | $613 | $513 | $568 |
| Gross Profit | $5 | $371 | $684 | $245 |
| % Margin | 1.7% | 37.7% | 57.2% | 30.1% |
| R&D Expenses | $769 | $849 | $1,015 | $832 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,931 | $2,983 | $2,633 | $2,684 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,699 | $3,833 | $3,648 | $3,516 |
| Operating Income | -$3,694 | -$3,462 | -$2,964 | -$3,271 |
| % Margin | -1,213.6% | -352% | -247.7% | -402.3% |
| Other Income/Exp. Net | $46 | $126 | $295 | -$42 |
| Pre-Tax Income | -$3,648 | -$3,336 | -$2,669 | -$3,314 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,945 | -$27,224 | -$2,639 | -$3,297 |
| % Margin | -1,296.1% | -2,768.4% | -220.6% | -405.5% |
| EPS | -34 | -15.35 | -0.56 | -0.19 |
| % Growth | -121.5% | -2,641.1% | -194.7% | – |
| EPS Diluted | -34 | -15.35 | -0.56 | -0.19 |
| Weighted Avg Shares Out | 572 | 1,773 | 31,519 | 17,742 |
| Weighted Avg Shares Out Dil | 572 | 1,773 | 31,519 | 17,742 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40 | $60 | $71 | $91 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $78 | $119 | $59 | $77 |
| EBITDA | -$3,616 | -$3,217 | -$2,905 | -$3,194 |
| % Margin | -1,187.8% | -327.2% | -242.8% | -392.8% |